in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Teva names Makhteshim Agan boss as new CEO
7:58 AM MST | January 9, 2014 | Deepti Ramesh
Erez Vigodman. Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) says that Erez Vigodman, 54, has been appointed as president and CEO, effective 1 February. Teva announced on 30 October 2013 that its president and CEO, Jeremy Levin, had stepped down. Vigodman is currently president and CEO of Makhteshim Agan Industries (Tel Aviv), the world’s leading generic agrochemical company. Vigodman will retain that position until 6 February. Teva's group executive v.p. and CFO, Eyal Desheh, who filled the role of CEO on an interim basis, will now return to...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee